Table 1.
Baseline characteristics
| Variable | Study group (n = 190) | Practice group (n = 97) | P value |
|---|---|---|---|
| Age (years) | 66.6 ± 5.4 | 67.7 ± 5.0 | 0.11 |
| Male | 113 (59.5) | 53 (54.6) | 0.43 |
| College and above | 57 (30.0) | 31 (32.0) | 0.73 |
| Paroxysmal atrial fibrillation | 131 (68.9) | 63 (64.9) | 0.49 |
| Diabetes | 33 (17.4) | 15 (15.5) | 0.68 |
| Hypertension | 122 (64.2) | 57 (58.8) | 0.37 |
| Dyslipidemia | 41 (21.6) | 25 (25.8) | 0.42 |
| Coronary heart disease | 30 (15.8) | 13 (13.4) | 0.59 |
| Heart failure | 10 (5.3) | 4 (4.1) | 0.78 |
| Level of anxiety# | 3.8 ± 1.3 | 3.6 ± 0.7 | 0.14 |
| Level of depression# | 2.7 ± 1.3 | 2.7 ± 1.1 | 0.72 |
| Smoker | 33 (17.4) | 14 (14.4) | 0.52 |
| CHA2DS2-VASc score (< 2 for males, < 3 for females) | 89 (46.8) | 40 (41.2) | 0.38 |
| Oral anticoagulants | 116 (61.1) | 56 (57.7) | 0.59 |
| Antiplatelet | 19 (10.0) | 12 (12.4) | 0.54 |
| ACEI/ARB | 57 (30.0) | 34 (35.1) | 0.38 |
| Statins | 91 (47.9) | 40 (41.2) | 0.28 |
Values are presented as the mean ± SD or n (%)
#Level of anxiety and depression assessed by visual analog scales